Chronic News and Research

RSS

Asia-Pacific Osteoporosis Meeting focuses on new strategies in the battle against osteoporosis

Today, one of the largest clinical bone events in the Asia-Pacific region opened at the Hong Kong Conference and Exhibition Centre, drawing close to 850 international delegates from over 60 countries. The IOF Regionals 4th Asia-Pacific Osteoporosis Meeting, which continues through to December 15, is organized by the International Osteoporosis Foundation in cooperation with the Hong Kong Osteoporosis Foundation and the Osteoporosis Society of Hong Kong.

12 Dec 2013

Association of Rehabilitation Nurses to receive applications for 2014 Mary Ann Mikulic Scholarship

The Association of Rehabilitation Nurses will now begin accepting applications for the 2014 Mary Ann Mikulic Scholarship. The Mary Ann Mikulic Scholarship offers one full conference registration for a first-time attendee to the 40th Anniversary ARN Annual Conference, October 29-November 1 in Anaheim, CA.

12 Dec 2013

Late-breaking abstracts on treatment of blood cancers and bleeding disorders presented at ASH meeting

A range of studies highlighting late-breaking research advances in the understanding and treatment of blood cancers and bleeding disorders are being presented today during the 55th American Society of Hematology Annual Meeting and Exposition in New Orleans.

12 Dec 2013

Research paper provides first evidence-based recommendations for using PRP in orthopaedic care

Platelet-rich plasma (PRP) has grabbed headlines in recent years for its role in helping some of sports' biggest stars return to play following injury -including golfer Tiger Woods, Super Bowl winner Hines Ward and NBA legend Kobe Bryant.

12 Dec 2013

Lund University researcher explores why type 2 diabetes raises dementia risk later in life

It is well known that type 2 diabetes raises the risk of dementia. The reasons for this are less clear, but one explanation could be insulin resistance in the brain, according to Malin Wennstr-m, a researcher at Lund University's Molecular Memory Research Unit. She has received EUR 700,000 from the Swedish Research Council to investigate her theory.

12 Dec 2013

Medivir initiates phase IIa trial to evaluate efficacy of simeprevir combination therapy in HCV-infected patients

Medivir AB (STO:MVIR-B) (OMX: MVIR), announces the initiation of a phase IIa trial in chronic genotype 1 hepatitis C infected patients to evaluate the efficacy, safety and tolerability of a 12-week combination therapy of simeprevir, TMC647055 and JNJ56914845, a NS5A replication complex inhibitor.

12 Dec 2013

Scientists develop new technique that results in better ways to relieve pain, monitor healing

Understanding the science behind pain, from a simple "ouch" to the chronic and excruciating, has been an elusive goal for centuries. But now, researchers are reporting a promising step toward studying pain in action.

12 Dec 2013

HCV antiviral therapy also improves diabetes outcomes

Researchers from Taiwan reveal that antiviral therapy for hepatitis C virus improves kidney and cardiovascular outcomes for patients with diabetes. Results of the study published in Hepatology, a journal of the American Association for the Study of Liver Diseases, show that incidences of kidney disease, stroke, and heart attack were lower in patients treated with pegylated interferon and ribavirin compared to HCV patients not treated with antivirals or diabetic patients not infected with the virus.

12 Dec 2013

MedImmune, Johns Hopkins University enter into $6.5M research collaboration

MedImmune, AstraZeneca’s global biologics research and development arm, and The Johns Hopkins University today announced they have entered into a five-year, $6.5 million research collaboration.

12 Dec 2013

Dietary amino acids improve sleep disturbances caused by brain injuries in animals

Scientists who fed a cocktail of key amino acids to mice improved sleep disturbances caused by brain injuries in the animals. These new findings suggest a potential dietary treatment for millions of people affected by traumatic brain injury (TBI)—a condition that is currently untreatable.

12 Dec 2013

Study finds that people with COPD twice likely to develop mild cognitive impairment, memory loss

A recent Mayo Clinic study found that people with chronic obstructive pulmonary disease (COPD) are about twice as likely to develop mild cognitive impairment (MCI) -- and chances are that it will include memory loss. The study was recently published in Mayo Clinic Proceedings.

12 Dec 2013

U.S. Marines investigate association between traumatic brain injury and risk of PTSD

In a novel study of U.S. Marines investigating the association between traumatic brain injury (TBI) and the risk of post-traumatic stress disorder (PTSD) over time, a team of scientists led by researchers from the Veterans Affairs San Diego Healthcare System and University of California, San Diego School of Medicine report that TBIs suffered during active-duty deployment to Iraq and Afghanistan were the greatest predictor for subsequent PTSD, but found pre-deployment PTSD symptoms and high combat intensity were also significant factors.

12 Dec 2013

Researchers awarded $25 million NIH grant to study critical limb ischemia treatment

A team of researchers from Brigham and Women's Hospital, Boston Medical Center and Massachusetts General Hospital has been awarded $25 million by the National Institutes of Health to conduct a four-year, randomized clinical trial-the BEST-CLI Trial (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia). The trial will compare traditional bypass surgery with the less invasive alternative of endovascular treatment for patients with critical limb ischemia.

11 Dec 2013

Crealta to acquire all assets of Savient Pharmaceuticals

Savient Pharmaceuticals, Inc. ("Savient") announced that it has reached agreement on the terms of an acquisition agreement with Crealta Pharmaceuticals LLC ("Crealta") through which Crealta would acquire substantially all of the assets of Savient, including all KRYSTEXXA® assets, for gross proceeds of approximately $120.4 million.

11 Dec 2013

New study aims to determine prevalence of pediatric chronic fatigue syndrome in Chicago area youth

The prevalence of chronic fatigue syndrome in children and the significant impairment it causes to their physical functioning, school attendance and performance, and extracurricular activities, are at the root of a new Chicago-based study led by DePaul University psychologist Leonard A. Jason.

11 Dec 2013

CatchMyPain App for patients suffering from chronic pain

Pain management as an independent medical field has been significantly growing during the last few decades. Doctors and clinics specialize in the treatment of pain in general and chronic pain specifically. These specialists often suggest using a pain diary to track the pain, see its development and adjust the treatment accordingly. CatchMyPain is an electronic version of such a pain diary and a great solution for patients suffering from chronic pain.

11 Dec 2013

Pharmacyclics presents ibrutinib trial data for B-cell malignancies at ASH meeting

Pharmacyclics, Inc. today announced results of 40 clinical, non-clinical and pre-clinical presentations on ibrutinib (IMBRUVICA™) at the 55TH Annual meeting of the American Society of Hematology (ASH) held in New Orleans, Dec 7 - 10, 2013.

11 Dec 2013

New report shows that Americans are making considerable progress in overall health

Americans are making considerable progress in their overall health, according to United Health Foundation's 2013 America's Health Rankings®: A Call to Action for Individuals & Their Communities. Nationwide, Americans improved in the majority of the measures captured by the Rankings.

11 Dec 2013

Many Americans still tend to avoid addressing own end-of-life issues

During the past two decades, high-profile legal cases surrounding end-of-life decisions have received widespread attention in the United States, prompting increased media focus and numerous debates on the subject.

10 Dec 2013

ART safe and effective for treating combat-related symptoms of PTSD among veterans

Accelerated Resolution Therapy, or ART, is a brief, safe, and effective treatment for combat-related symptoms of post-traumatic stress disorder among veterans and U.S. service members, researchers at University of South Florida College of Nursing report in a new study. They found this newer treatment -- a combination of evidence-based psychotherapies and use of eye movements -- was shorter and more likely to be completed, than conventional therapies formally endorsed by the U.S. Department of Defense and the Veterans Administration.

9 Dec 2013

Chronic News and Research

Asia-Pacific Osteoporosis Meeting focuses on new strategies in the battle against osteoporosis

Association of Rehabilitation Nurses to receive applications for 2014 Mary Ann Mikulic Scholarship

Late-breaking abstracts on treatment of blood cancers and bleeding disorders presented at ASH meeting

Research paper provides first evidence-based recommendations for using PRP in orthopaedic care

Lund University researcher explores why type 2 diabetes raises dementia risk later in life

Medivir initiates phase IIa trial to evaluate efficacy of simeprevir combination therapy in HCV-infected patients

Scientists develop new technique that results in better ways to relieve pain, monitor healing

HCV antiviral therapy also improves diabetes outcomes

MedImmune, Johns Hopkins University enter into $6.5M research collaboration

Dietary amino acids improve sleep disturbances caused by brain injuries in animals

Study finds that people with COPD twice likely to develop mild cognitive impairment, memory loss

U.S. Marines investigate association between traumatic brain injury and risk of PTSD

Researchers awarded $25 million NIH grant to study critical limb ischemia treatment

Crealta to acquire all assets of Savient Pharmaceuticals

New study aims to determine prevalence of pediatric chronic fatigue syndrome in Chicago area youth

CatchMyPain App for patients suffering from chronic pain

Pharmacyclics presents ibrutinib trial data for B-cell malignancies at ASH meeting

New report shows that Americans are making considerable progress in overall health

Many Americans still tend to avoid addressing own end-of-life issues

ART safe and effective for treating combat-related symptoms of PTSD among veterans

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News